Geschäft · 27.12.20131 Min. Lesezeit
Withdrawal of Approval of New Animal Drug Applications; Roxarsone
Lokale automatische Übersetzung · Originalsprache der Quelle
Zusammenfassung
The Food and Drug Administration (FDA) is withdrawing approval of five new animal drug applications (NADAs) for roxarsone oral dosage form products at the sponsor's request because the products are no longer manufactured or marketed.